- Report
- December 2023
- 80 Pages
China
From €1337EUR$1,500USD£1,156GBP
- Report
- December 2023
- 180 Pages
Global
From €1114EUR$1,250USD£964GBP
€2228EUR$2,500USD£1,927GBP
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 80 Pages
Saudi Arabia
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 80 Pages
India
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 80 Pages
Germany
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 80 Pages
France
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 80 Pages
South Korea
From €1337EUR$1,500USD£1,156GBP
- Report
- May 2023
- 100 Pages
Africa
From €1783EUR$2,000USD£1,542GBP
- Report
- May 2023
- 255 Pages
Global
From €1114EUR$1,250USD£964GBP
€2228EUR$2,500USD£1,927GBP
- Report
- October 2024
- 73 Pages
Global
From €3500EUR$4,206USD£3,133GBP
- Report
- May 2026
- 211 Pages
Australia
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 212 Pages
Brazil
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 213 Pages
Canada
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 214 Pages
Germany
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 215 Pages
India
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 216 Pages
Indonesia
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 217 Pages
Italy
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 218 Pages
Japan
From €4323EUR$4,850USD£3,739GBP
- Report
- May 2026
- 219 Pages
Malaysia
From €4323EUR$4,850USD£3,739GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more